Brief: Qualigen Therapeutics Announces Partnership With Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies For QN-302
06/07/2022 14:01
July 6 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS ANNOUNCES PARTNERSHIP WITH HANDE
SCIENCES
TO SCALE-UP MANUFACTURING TO SUPPORT IND-ENABLING STUDIES FOR
QN-302
* QUALIGEN THERAPEUTICS - AGREEMENT WITH HANDE PROVIDES FOR
PROCESS DEVELOPMENT AND SCALE-UP BATCHES OF MATERIAL FOR
COMPANY'S GLP TOXICOLOGY STUDIES
Source text for Eikon: ID:nGNXbW2G32
Further company coverage: QLGN.O
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise